Correct! The problem for big pharma is Direct because if it can be used without a checkpoint inhibitor and achieve the same results in almost all solid tumor cancers then you don't want to add fuel to the fire that will burn your business down. Any questions as to why there would be no incentive to help NWBO's financial situation through a "fair" partnership where they are the ones on a leash? Best wishes.
Market Data 
Markets 
AI
